Acquisition of an xcelligence rtca-MP equipment package

Ended Purchase Order Awarded

Contract number
HHSN261201600007A
Awardee
Awarding agency
Obligated
$99,000

Award facts

Opportunity
Contract value 100% obligated
$99,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

About this award

This federal contract award was made by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Acea Biosciences, Inc. for the acquisition of an xCELLigence RTCA-MP equipment package. The $99,000.00 firm fixed-price purchase order does not have a set-aside designation. Acea Biosciences, a for-profit life sciences company, has received over 20 prior federal contract awards from agencies including the USDA, HHS, VA, and Navy to provide specialized equipment and services related to flow cytometry, cell analysis, and biosensing technology. This contract supports the research efforts of the National Cancer Institute.

Quick answers

Who was awarded contract HHSN261201600007A?

HHSN261201600007A was awarded to Acea Biosciences, Inc. by National Cancer Institute (National Institutes of Health) on June 17, 2016.

How much is contract HHSN261201600007A worth?

The government has obligated $99,000 on HHSN261201600007A.

Was contract HHSN261201600007A competed?

The extent of competition for HHSN261201600007A was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award